Wolverine Asset Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$361K Buy
48,700
+10,500
+27% +$110K ﹤0.01% 993
2025
Q4
$449K Buy
+38,200
New +$412K ﹤0.01% 953
2025
Q1
Sell
-4,300
Closed -$70.9K 1702
2024
Q4
$70.9K Sell
4,300
-4,400
-51% -$68.3K ﹤0.01% 1152
2024
Q3
$128K Buy
+8,700
New +$136K ﹤0.01% 1082
2020
Q4
Sell
-500
Closed -$18K 1806
2020
Q3
$18K Hold
500
﹤0.01% 1415
2020
Q2
$15K Buy
+500
New +$13.9K ﹤0.01% 1394

Other funds holding NEO

Wolverine Asset Management's NEO Position: Q1 2026 in Review

Wolverine Asset Management opened a new position in NeoGenomics (NEO) in Q1 2026: 23,343 shares worth $173K. The stake represents ﹤0.01% of the portfolio and ranks #1106 among its holdings. This is a return to the name: Wolverine Asset Management previously reported a position in NEO as recently as Q4 2024.

Wolverine Asset Management first reported a position in NEO in Q1 2022 and has held it in 3 quarters since. The position peaked at $1.73M in Q1 2022. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Wolverine Asset Management held 23,343 shares of NeoGenomics worth $173K as of Q1 2026.
  • NeoGenomics was a new Wolverine Asset Management position in Q1 2026.
  • NeoGenomics made up ﹤0.01% of Wolverine Asset Management's portfolio in Q1 2026, its #1106 holding.
  • Wolverine Asset Management first reported a position in NeoGenomics in Q1 2022 and has held it in 3 quarters since.
  • Wolverine Asset Management's NeoGenomics position peaked at $1.73M in Q1 2022.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Wolverine Asset Management's 13F filing for Q1 2026, filed 4 May 2026.